For pharma, volatility and value are two sides of the same coin
But beyond output consistency, a diversified manufacturing base is important: EDB
Singapore
FOR the four months to July, Singapore's export-oriented drug industry notched up double-digit yearly growth, while July exports surged a stunning 109 per cent - yet industry players are hard put to forecast a consistent trajectory.
Rather, the prognosis for the notoriously volatile sector is for it to hold "steady".
TRENDING NOW
Keppel H1 net profit drops 59% to S$155 million on legacy rig impairments, M1 deal fallout
Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart
Singtel explores Nasdaq-SGX dual listing for data centre arm Nxera, local data centre Reit
UOB CEO’s youngest child Grant Wee turns burnout into a wellness business